Category: Drug Discovery Research
Evolving Drug Discovery Strategies: Structure-Based Design, Targeted Degraders, and Human-Relevant Models to Reduce Attrition
Evolving Strategies in Drug Discovery Research Drug discovery continues to pivot from one-size-fits-all screening toward more precise, biology-driven approaches. Researchers now combine high-throughput screening with target-centric strategies to improve hit quality and reduce late-stage attrition. Key shifts include better target validation, improved structural insight, and the use of more predictive biological models — all aimed…
Read More
Modern Drug Discovery: Prioritizing Target Validation, Human-Relevant Models, and Early Safety to Reduce Late-Stage Attrition
Drug discovery research is evolving through a convergence of better tools, smarter screening strategies, and more predictive biological models that together shrink cycles from idea to candidate while improving clinical success odds. Researchers balancing creativity and rigor now prioritize target confidence, early safety assessment, and human-relevant models to reduce late-stage attrition. Target identification and validationRobust…
Read More
Making Drug Discovery Predictive: CRISPR, Organoids, Cryo‑EM and Targeted Degradation
Drug discovery is undergoing a transformative phase as new experimental platforms and smarter translational strategies converge to shorten timelines and improve success rates. Today’s breakthroughs are less about single silver bullets and more about integrating technologies that better mimic human biology, predict safety, and prioritize the most promising targets early. What’s changing in drug discoveryTraditional…
Read More
Targeted Protein Degradation in Drug Discovery: PROTACs, Molecular Glues, Key Challenges and Best Practices
Targeted protein degradation is reshaping drug discovery by turning previously “undruggable” proteins into actionable therapeutic targets. This strategy harnesses the cell’s own quality-control machinery to remove disease-causing proteins rather than merely inhibit their activity, opening routes to treat oncology, neurodegeneration, infectious diseases, and more. How targeted degradation worksThe core idea is to recruit an E3…
Read More
Integrating Fragment-Based Lead Discovery and Targeted Protein Degradation: Practical Strategies to Accelerate Drug Discovery
Drug discovery research is evolving rapidly, driven by advances in chemistry, biology, and translational sciences. Two complementary strategies that are shaping modern pipelines are fragment-based lead discovery (FBLD) and targeted protein degradation. Together they offer routes to tackle challenging targets, improve lead quality, and shorten the path from target validation to candidate selection. Why these…
Read More
Reducing Late-Stage Failures in Drug Discovery: Integrated Target Selection, Organoids, Biomarkers, ADME/Tox and Data‑Driven Lead Design
Drug discovery remains one of the most challenging and rewarding fields in biomedical research. Progress depends on connecting molecular insight with robust experimental systems, and a few converging strategies are improving success rates and reducing late-stage failures. Integrated target selection and validationSelecting the right biological target is foundational. Functional genomics screens using CRISPR-based perturbations, coupled…
Read More
Targeted Protein Degradation: How PROTACs and Molecular Glues Are Redefining Drug Discovery Strategies
Targeted Protein Degradation: Redefining Drug Discovery Strategies Targeted protein degradation has emerged as a transformative approach in drug discovery, offering a way to eliminate disease-causing proteins rather than simply inhibit their activity. Two main modalities dominate the field: proteolysis-targeting chimeras (PROTACs) and molecular glues. Both exploit the cell’s ubiquitin–proteasome system to mark unwanted proteins for…
Read More
Accelerating Drug Discovery with Modern Technologies: Organoids, Structural Design, Proteomics, and Single-Cell Biomarkers
How modern technologies are accelerating drug discovery research Drug discovery research is evolving rapidly as multiple technologies converge to make target validation, lead identification, and translational development faster and more predictive. Companies and academic teams are combining improved biology models, advanced structural tools, and chemical strategies to reduce late-stage failures and bring more effective therapies…
Read More
Targeted Protein Degradation: PROTACs, Molecular Glues, and the Future of Drugging Undruggable Targets
Targeted protein degradation is reshaping how researchers approach previously “undruggable” targets and offering a fresh toolkit for drug discovery. Rather than blocking a protein’s active site, degradation strategies remove the problematic protein from the cell, producing catalytic effects and opening therapeutic options across oncology, neurodegeneration, inflammation, and infectious disease. How targeted degradation worksTwo main modalities…
Read More
Targeted Protein Degradation (PROTACs): A Practical Guide to Strategies, Challenges, and Therapeutic Opportunities
Targeted protein degradation is reshaping the landscape of drug discovery by offering a fundamentally different way to control disease biology. Instead of blocking a protein’s activity with traditional inhibitors, degradation strategies remove the protein from the cell, opening therapeutic possibilities for targets previously considered “undruggable.” How targeted protein degradation worksSmall molecules called degraders recruit an…
Read More